Posts by: Iqra Mumal

A new study shows that tumors that constantly express the protein IDO1 (indoleamine 2,3-dioxygenase) are sensitive to COX-2 inhibitors, which may provide an increase in T-cell anti-tumor function. The ... Read more

July 12, 2017

Gene Expression Analysis Helps Determine Sensitivity to Immunotherapies

News

Researchers at Johns Hopkins University have discovered that variations in gene expression levels can provide insight into mechanisms that allow tumors to respond to immunotherapies. The study, “Transcriptional Mechanisms ... Read more

July 5, 2017

EFFECTOR to Work with Pfizer and Merck on Evaluating Colorectal Cancer Immunotherapy Combo

News

EFFECTOR Therapeutics will team up with Pfizer and Merck’s operation in Darmstadt, Germany, to evaluate an immuno-oncology combination theapy in patients with microsatellite stable colorectal cancer. Set to begin in the third quarter of ... Read more

June 29, 2017June 29, 2017

Blood Protein Levels May Predict Cervical Cancer Patients Likely to Benefit from Advaxis’ Immunotherapy

News

Measuring the blood levels of certain proteins before treatment may help identify patients more likely to benefit from Advaxis‘ immunotherapy vaccine candidate axalimogene filolisbac (axal). In the GOG/NRG-0265 Phase 2 ... Read more